Search Results - K Weisel

Refine Results
  1. 1

    P973: REAL-WORLD STUDY ON ADOPTION OF STANDARD OF CARE (SOC) FOR FRONTLINE TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA (FLTEMM) PATIENTS BETWEEN 2017 AND 2020/2021 ACROSS FRANCE, GERMANY,... by K. Weisel, A. Wadlund, G. Gungor, E. Dergarabetian, C. Pacheco, N. Masurkar, P. Rodriguez-Otero

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    Hyperkyphotic changes in sagittal spinopelvic profile are associated with increased pain and impaired function in multiple myeloma patients by J. Kylies, M. Dirks, E. Brauneck, M. Dreimann, W. Wolters, K. Weisel, L.G. Leonhardt, L. Viezens

    Published in Brain and Spine (2024-01-01)
    Get full text
    Article


  3. 3

    Additive effects of adjunctive app-based interventions for mental disorders - A systematic review and meta-analysis of randomised controlled trials by Lukas M. Fuhrmann, Kiona K. Weisel, Mathias Harrer, Jennifer K. Kulke, Harald Baumeister, Pim Cuijpers, David D. Ebert, Matthias Berking

    Published in Internet Interventions (2024-03-01)
    Get full text
    Article


  4. 4

    Support after return to alcohol use: a mixed-methods study on how abstinence motivation and app use change after return to alcohol use in an app-based aftercare intervention for in... by Catharina Lang, Kiona K. Weisel, Sebastian Saur, Lukas M. Fuhrmann, Antonie Schoenleber, Daniela Reichl, Niklas Enewoldsen, Sabine Steins-Loeber, Matthias Berking

    Published in Addiction Science & Clinical Practice (2024-05-01)
    Get full text
    Article


  5. 5

    P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALIDOMIDE–PRETREATED MULTIPLE MYELOMA: A SUBANALYSIS OF OPTIMISMM BY FRAILTY by A. Oriol, M. Dimopoulos, F. Schjesvold, M. Beksac, M. Yagci, A. Larocca, S. Guo, Y. Mu, K. Hong, S. Dhanasiri, P. Richardson, K. Weisel

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    Do Nonsuicidal Severely Depressed Individuals with Diabetes Profit from Internet-Based Guided Self-Help? Secondary Analyses of a Pragmatic Randomized Trial by Sandra Schlicker, Kiona K. Weisel, Claudia Buntrock, Matthias Berking, Stephanie Nobis, Dirk Lehr, Harald Baumeister, Frank J. Snoek, Heleen Riper, David D. Ebert

    Published in Journal of Diabetes Research (2019-01-01)
    Get full text
    Article


  7. 7

    Challenges in Recruiting University Students for Web-Based Indicated Prevention of Depression and Anxiety: Results From a Randomized Controlled Trial (ICare Prevent) by Felix Bolinski, Annet Kleiboer, Koen Neijenhuijs, Eirini Karyotaki, Reinout Wiers, Lisa de Koning, Corinna Jacobi, Anna-Carlotta Zarski, Kiona K Weisel, Pim Cuijpers, Heleen Riper

    Published in Journal of Medical Internet Research (2022-12-01)
    Get full text
    Article


  8. 8

    P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LA... by N. W. van de Donk, S. Guo, L. Shi, J. Lord-Bessen, D. Tang, L. Karlin, K. Weisel, K. Ramasamy, P. C. Abad, A. Amin, S. Amin, S. Lonial

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  9. 9

    P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS FROM THE PHASE 2 GMMG-DA... by L. Leypoldt, M. Gavriatopoulou, B. Besemer, H. Salwender, M.-S. Raab, A. Nogai, C. Khandanpour, V. Runde, M. Zago, P. Martus, H. Goldschmidt, C. Bokemeyer, M. Dimopoulos, K. Weisel

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  10. 10

    Internet-based indicated prevention of anxiety and depression disorder onset three-arm randomized clinical trial by Anna-Carlotta Zarski, Kiona K. Weisel, Thomas Berger, Tobias Krieger, Michael P. Schaub, Matthias Berking, Dennis Görlich, Corinna Jacobi, Rosa Baños, Cristina Botella, Rocio Herrero, David D. Ebert

    Published in npj Digital Medicine (2025-10-01)
    Get full text
    Article


  11. 11

    P972: INDIRECT COMPARISON OF TECLISTIMAB IN MAJESTEC-1 VERSUS PHYSICIAN’S CHOICE OF THERAPY IN LONG-TERM FOLLOW-UP OF TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA IN D... by K. Weisel, A. Chari, S. Z. Usmani, H. Goldschmidt, M.-V. Mateos, K. Qi, A. Londhe, S. Nair, X. Lin, L. Pei, E. Ammann, R. Kobos, J. Smit, T. Parekh, M. Slavcev, P. Moreau

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  12. 12

    P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE L... by H. Einsele, P. Moreau, M. Delforge, N. W. van de Donk, F. Ghilotti, J. Diels, A. Elsada, V. Strulev, L. Pei, R. Kobos, J. Smit, M. Slavcev, K. Weisel, M.-V. Mateos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  13. 13

    Identification of novel immune checkpoints relevant in bone metastasis-derived immune cells by L.G. Leonhardt, E. Brauneck, M. Kruppa, N. Kruppa, A. Dukek, Y. Wahid, J. Krüger, J. Kylies, K. Weisel, A.M. Asemissen, J. Schulze zur Wiesch, C. Bokemeyer, W. Fiedler, J. Wellbrock, F. Brauneck, L. Viezens

    Published in Brain and Spine (2024-01-01)
    Get full text
    Article


  14. 14

    P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAP... by A. Spencer, P. Moreau, M.-V. Mateos, H. Goldschmidt, K. Suzuki, M.-D. Levin, P. Sonneveld, S.-S. Yoon, S. Z. Usmani, K. Weisel, D. Reece, T. Ahmadi, H. Pei, W. Garvin Mayo, X. Gai, J. Carey, R. Carson, M. A. Dimopoulos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  15. 15

    P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE... by P Sonneveld, A Chanan-Khan, K Weisel, AK Nooka, T Masszi, M Beksac, I Spicka, V Hungria, M Munder, MV Mateos, TM Mark, MD Levin, T Ahmadi, X Qin, W Garvin Mayo, X Gai, J Carey, R Carson, A Spencer

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  16. 16

    P936: TIME TO RESPONSE, DURATION OF RESPONSE, AND PATIENT-REPORTED OUTCOMES WITH DARATUMUMAB PLUS RD VS RD ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NDMM: SUBGROUP ANALYSIS OF T... by T. Facon, S. K. Kumar, T. Plesner, P. Moreau, N. Bahlis, H. Goldschmidt, M. O’Dwyer, A. Perrot, C. P. Venner, K. Weisel, J. R. Mace, N. Raje, M. Tiab, M. Macro, L. Frenzel, X. Leleu, H. Pei, F. Borgsten, S. Z. Usmani

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  17. 17

    P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by N. W. C. J van de Donk, R Popat, C Hulin, S Jagannath, A Oriol, P. G Richardson, T Facon, K Weisel, J. T Larsen, M Minnema, A Abdallah, A. Z Badros, S Knop, E. A Stadtmauer, M Chen, T. V Nguyen, A Amin, T Peluso, S Lonial

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  18. 18

    P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY by A. Suvannasankha, N. Bahlis, S. Trudel, K. Weisel, C. Koenecke, A. Oriol, P. M. Voorhees, A. A. Alonso, N. S. Callander, M. V. Mateos Manteca, N. Reddy, S. Hakim, N. Patel, D. Williams, R. C. Jewell, X. Zhou, I. Gupta, A. K. Nooka

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  19. 19

    P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESS... by H Einsele, AD Cohen, M Delforge, J Hillengass, H Goldschmidt, K Weisel, M-S Raab, C Scheid, JM Schecter, KC De Braganca, H Varsos, T-M Yeh, L Wang, M Vogel, C Corsale, M Akram, L Pacaud, T Nesheiwat, M Agha, YC Cohen

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  20. 20

    P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPO... by K. Weisel, M.-V. Mateos, L. Vincent, T. Martin, J. G. Berdeja, A. Jakubowiak, S. Jagannath, Y. Lin, P. Thilakarathne, F. Ghilotti, J. Diels, B. Haefliger, C. Hague, A. Gonzalez, J. M. Schecter, K. S. Gries, V. Strulev, T. Nesheiwat, L. Pacaud, H. Einsele, P. Moreau

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: